Fundraising Fox

Nuvig

7 known investors

nuvigtherapeutics.com ↗

Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation. The company targets patients with chronic inflammatory and autoimmune conditions.

BiotechHealthtechMedical Devicesin /nuvig-therapeutics-inc@nuvigtx

Investors · 7

B Capital GroupManhattan Beach · $10M – $50M
B4 Capital$10M – $50M
Global BioAccess FundNew York · $10M
Mission BiocapitalSan Francisco · $500K
Sanofi VenturesCambridge · $5M
Digitalis VenturesreportedNew York · $100K – $10M
Norwest Venture PartnersreportedMenlo Park · $10M – $30M

In the news